TickerFacts.

Caris Life Sciences, Inc. (CAI): Operating Income

Annual figures by period end, from SEC filings.

$45.11M
Year ended 2025-12-31
$153.26M
Trailing 12 months to 2026-06-30
2023-12-31: -$319.55M2024-12-31: -$257.12M2025-12-31: $45.11M$45.11M
2023-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31$45.11Mn/m2026-03-03, From 2025-01-01
2024-12-31-$257.12Mn/m2026-03-03, From 2024-01-01
2023-12-31-$319.55Mn/a2026-03-03, From 2023-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Caris Life Sciences, Inc. (CAI)2025-12-31$45.11Mn/m
Guardant Health, Inc. (GH)2025-12-31-$437.25Mn/m
Veracyte, Inc. (VCYT)2025-12-31$57.78M+257.9%
CareDx, Inc. (CDNA)2025-12-31-$30.78Mn/m
Castle Biosciences Inc (CSTL)2025-12-31-$42.81Mn/m
RadNet, Inc. (RDNT)2025-12-31$61.99M-40.7%
Fulgent Genetics, Inc. (FLGT)2025-12-31-$91.10Mn/m
BillionToOne, Inc. (BLLN)2025-12-31$16.02Mn/m
Natera, Inc. (NTRA)2025-12-31-$309.91Mn/m

Compare CAI, GH, VCYT, CDNA side by side · Screen every company in Services-Medical Laboratories ↗